Gujarat Themis Biosyn Limited — Others, 13-06-2025: Change in Director(s)

Gujarat Themis Biosyn has announced a board meeting that approved key leadership changes and strategic shifts. CEO Tapas Guha Thakurata resigned due to health reasons, effective end of June, and Dr. Sachin D. Patel was re-designated as Managing Director for five years from July. The company withdrew its earlier proposed merger with Themis Medicare to prioritize expanding its core fermentation-based pharmaceutical intermediates and API business, focusing on organic growth and collaborations to enhance shareholder value.